The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes
- 15 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 194 (4) , 486-492
Abstract
Rationale: There is uncertainty about the effects of treating obstructive sleep apnea on glycemic control in patients with type 2 diabetes. Objectives: To determine whether treatment of obstructive sleep apnea in patients with type 2 diabetes improves glycemic control. Methods: In this trial, we randomized patients with type 2 diabetes and no previous diagnosis of obstructive sleep apnea, with a glycated hemoglobin level of 6.5–8.5%, and an oxygen desaturation index of 15 or more events per hour to positive airway pressure therapy or to usual care. Measurements and Main Results: A total of 416 patients met the entry criteria as determined by each site and were randomized. Of the 298 participants who met centrally adjudicated entry criteria, no differences between the study groups were seen for change in glycated hemoglobin. Furthermore, there were no between-group differences when analyses were restricted to those with poorer baseline glycemic control, those with more severe sleep apnea, or those who were adherent to therapy. A greater fall in diastolic blood pressure occurred in the positive airway pressure group than in the usual care group (−3.5 mm Hg vs. −1.5 mm Hg; P = 0.07). This difference was significant in those who were adherent to positive airway pressure therapy (−4.4 mm Hg vs. −1.6 mm Hg; P = 0.02). There was a significant reduction in sleepiness in the positive airway pressure therapy group (P < 0.0001). Quality of life assessment revealed improvements in vitality, mental health, and mental component summary scores in the positive airway pressure therapy group. Conclusions: This trial showed no effect of positive airway pressure therapy on glycemic control in patients with relatively well-controlled type 2 diabetes and obstructive sleep apnea. Clinical trial registered with www.clinicaltrials.gov (NCT00509223).Keywords
Funding Information
- ResMed Science Centre, ResMed Ltd
- National Health and Medical Research Council
This publication has 24 references indexed in Scilit:
- Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Diabetes Mellitus Prevalence and Control in Sleep-Disordered BreathingChest, 2014
- Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Research and Clinical Practice, 2014
- Meta-analysis: Continuous Positive Airway Pressure Improves Insulin Resistance in Patients with Sleep Apnea without DiabetesAnnals of the American Thoracic Society, 2013
- Obstructive sleep apnoea and the risk of type 2 diabetes: A meta‐analysis of prospective cohort studiesRespirology, 2012
- Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesDiabetes Care, 2009
- Slow-wave sleep and the risk of type 2 diabetes in humansProceedings of the National Academy of Sciences, 2008
- Intermittent Hypoxia Causes Insulin Resistance in Lean Mice Independent of Autonomic ActivityAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Type 2 Diabetes, Glycemic Control, and Continuous Positive Airway Pressure in Obstructive Sleep ApneaArchives of internal medicine (1960), 2005
- The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsNew England Journal of Medicine, 1993